Health TrialsbyHealthPanel

Albumin-bound Paclitaxel (II)

1

Review clinical trials related to Albumin-bound Paclitaxel (II). Use filters to narrow results by trial status, phase, treatment, biological sex and sponsor.

Condition / disease
Location
Status: Not yet recruiting

Albumin-bound Paclitaxel (II) in Combination With Gemcitabine as First Line Therapy for Metastatic Pancreatic Cancer

This is a prospective, multicenter, open-label, single-arm study in participants with metastatic pancreatic adenocarcinoma who have not received any prior systemic anti-tumor therapy for advanced disease. To evaluate the efficacy and safety of albumin-bound paclitaxel (II) combined with gemcitabine for first-line treatment of metastatic pancreatic cancer.

Participants needed: 59
Trial details
Phase: Phase 2Age: 18-75Biological sex: AllType: InterventionalSponsor: The First Affiliated Hospital with Nanjing Medical UniversityUpdated: Sep 21, 2026
Eligibility criteria

1.Age 18-75 years; 2.Histopathologically or cytologically confirmed metastatic p...

1.Participants with a history of other malignancies within the past 5 years (wit...

Read more